Novo Nordisk to spend $1.2B for new rare disease drug factory in Denmark

Just days after winning FTC approval to take on three of Catalent’s facilities, Novo Nordisk said it is investing DKK 8.5 billion ($1.2 billion) to build a new factory in Denmark to ...